首页> 美国卫生研究院文献>Annals of Intensive Care >Impact of corticosteroid treatment on clinical outcomes of influenza-associated ARDS: a nationwide multicenter study
【2h】

Impact of corticosteroid treatment on clinical outcomes of influenza-associated ARDS: a nationwide multicenter study

机译:糖皮质激素治疗对流感相关ARDS临床结局的影响:一项全国性的多中心研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sensitivity analysis. Using univariate logistic regression analyses, the effects of corticosteroid treatment (defined by various criteria) on the hospital mortality were assessed, and the odds ratios (with 95% confidence intervals) were presented. Corticosteroid treatment was defined by achieving various cumulative hydrocortisone equivalent doses by various ICU days. Corticosteroid treatment was significantly associated with hospital mortality for all proposed criteria. There was a trend that the earlier use of corticosteroid was associated with the higher odds of hospital mortality. The criteria using cumulative hydrocortisone equivalent dose of ≥ 200 mg by the end of the third ICU day (ICU Day 3) provided the highest odds of hospital mortality
机译:敏感性分析。使用单变量logistic回归分析,评估了皮质类固醇治疗(由各种标准定义)对医院死亡率的影响,并提出了比值比(置信区间为95%)。皮质类固醇治疗的定义是,在不同的ICU日内达到各种累积的氢化可的松当量剂量。对于所有提议的标准,皮质类固醇治疗与医院死亡率显着相关。有一种趋势,即早期使用皮质类固醇与医院死亡率更高的可能性有关。在ICU第3天(ICU第3天)结束时使用≥200 mg的氢化可的松当量累积剂量的标准提供了最高的医院死亡率

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号